Francesca Zara

Dr. Francesca Zara


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
FGFrancesca Gaffuri
Francesca Gaffuri
FZFrancesca Zara
Francesca Zara
LGLaura Grassi
Laura Grassi
Cinzia MasperoCinzia Maspero
Cinzia Maspero
Objectives: This study aimed to evaluate maxillary arch width increase in juvenile patients requiring space gain, but without skeletal transverse discrepancies necessitating orthopedic expansion. The comparison focused on the effects of Rapid Maxillary Expansion (RME) using Hyrax expanders and dentoalveolar expansion via Invisalign First. Methods: This retrospective longitudinal study analyzed digital dental models of 38 patients (19 males and 19 females, aged 8 ± 2 years) undergoing maxillary expansion at the Department of Biomedical, Surgical, and Dental Science, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico (Milan, Italy). Patients were divided into two groups: one treated with Hyrax expanders (n = 19) and the other with Invisalign First (n = 19). Intraoral scans were taken before (T0) and after treatment (T1), and measurements were performed using Mimics Materialize 21.0 software. Statistical analysis included t-tests, ANOVA, and regression models to assess differences in maxillary expansion between groups. Results: Both groups showed statistically significant transverse arch increases (p < 0.01). Hyrax achieved greater expansion at the deciduous canine level, while Invisalign showed more at the deciduous molar level. First permanent molar expansion was similar. ICC for reliability was excellent (>0.97). No significant differences in sex or Angle class distribution were observed. Conclusions: Hyrax and Invisalign First both produce measurable maxillary expansion, but they serve distinct roles. While Hyrax expanders provide rapid skeletal expansion, Invisalign First offers a less invasive alternative for dentoalveolar widening with controlled force application. They should not be used interchangeably. Appliance selection must be tailored to the severity and nature of the transverse deficiency.

1 June 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
RCRoberta Crispino
Roberta Crispino
FZFrancesca Zara
Francesca Zara
MVMassimiliano Vella
Massimiliano Vella
LCLara Colaianni
Lara Colaianni
Cinzia MasperoCinzia Maspero
Cinzia Maspero
Alberto CaprioglioAlberto Caprioglio
Alberto Caprioglio
Objective: This systematic review aims to evaluate the effects of statin administration on orthodontic tooth movement (OTM) and post-treatment relapse in animal models. Materials and Methods: Following PRISMA guidelines and PROSPERO registration (CRD42025612449), a comprehensive literature search was performed in PubMed, Scopus, and the Cochrane Library up to December 2025. The search strategy included studies on animal models treated with any form of statin during OTM or relapse phases. Eligibility criteria were defined using the PICOS framework. Data extraction focused on study characteristics, statin administration protocol, orthodontic mechanics, and both histological and molecular markers of bone remodeling. Risk of bias was assessed with SYRCLE’s tool. Results: Seven in vivo animal studies met the inclusion criteria. Simvastatin and atorvastatin were investigated using heterogeneous experimental models, doses, administration routes, orthodontic mechanics, and follow-up periods. Findings suggested that statins may reduce active orthodontic tooth movement or post-orthodontic relapse in some experimental settings, but effects were not uniform across studies. Histological outcomes, when reported, generally indicated reduced osteoclast activity, fewer resorption lacunae, or more mature alveolar bone in statin-treated animals. Molecular outcomes were less consistently reported and mainly involved OPG/RANKL-related pathways, Runx2, or ALP expression. Conclusions: Statins, particularly simvastatin, show potential to modulate orthodontic tooth movement and reduce relapse by influencing bone metabolism. Nevertheless, due to methodological variability and the exclusive reliance on animal models, these results cannot yet be translated into clinical recommendations. Current preclinical evidence suggests that statins may modulate bone remodeling during active orthodontic tooth movement and after appliance removal. However, the evidence remains limited to a small number of heterogeneous animal studies with incomplete reporting of key outcomes and several unclear risk-of-bias domains. Clinical translation is premature, and more standardized preclinical studies are required before human investigations can be justified.

12 November 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
GDGiacomo D'Angeli
Giacomo D'Angeli
FZFrancesca Zara
Francesca Zara
FAFrancesca Arienzo
Francesca Arienzo
Daniela MessineoDaniela Messineo
Daniela Messineo
MCMauro Celli
Mauro Celli
ACAlessandro Corsi
Alessandro Corsi
Bisphophonates (BPs) are widely used in Osteogenesis imperfecta (OI). Cone Beam Computed Tomography (CBCT) shows clinical usefulness in evaluating impacted teeth and adjacent structure relationships, extraction socket healing, bone mineral density (BMD) and BP-related jaw osteonecrosis (BRONJ). The aim of the study was to compare alveolar sockets and the adjacent bone area before and after third molar extraction in OI type I (OI-I) adolescents treated with BPs and age-matched healthy subjects (HSs) by CBCT. Methods: Five adolescents with genetically proven OI-I treated with BPs (three males and two females, mean age: 15.2 ± 1.78 years) and four age-matched healthy subjects (two males and two females, mean age: 15.5 ± 1.29 years) were included in this study. Eight Regions of Interest (ROIs) were evaluated: between 3.7 and 3.8 (ROI-1) and 4.7 and 4.8 (ROI-2); after 3.8 (ROI-3) and 4.8 (ROI-4); alveolar sockets 3.8 (ROI-5) and 4.8 (ROI-6); left (ROI-7) and right (ROI-8) cortical bone. Results: ROIs were evaluated on both sides of the mandible for all the subjects except one OI patient in which CBCTs were performed pre- and-post third molar extraction only on the right side. CBCT was performed 12.8 ± 4.60 and 11.5 ± 2.51 days before and 8.0 ± 1.41 and 7.7 ± 0.5 months after extraction in OI-I and HSs, respectively. BPs were discontinued 62.0 ± 36.5 months before extraction. None of the OI-I adolescents developed BRONJ. Statistically significant greater values were observed in OI-I for ROI-1 and -2 (p = 0.0464), ROI-3 and -4 (p = 0.0037) and ROI-7 and -8 (p = 0.0079) after extraction. Conclusions: This descriptive study confirms that, in OI-I adolescents treated with BPs, third molar extraction is safe, and socket healing occurs properly. In addition, it demonstrates that, if the same device and imaging conditions are used and comparisons to predetermined standard values are avoided, CBCT can be used to monitor BMD changes. The significant greater BMD observed for different ROIs in OI-I could reflect the increased secondary mineralization related to the BP-dependent reduction in bone turnover.